Health & Fitness Genetic sequencing: Low rate of downstream costs demonstrate it’s worth the investment By Daniel Janson - March 25, 2018 0 739 Share on Facebook Tweet on Twitter Researchers analyzed the immediate cost of sequencing plus downstream spending six months after information was returned to physicians and patients and found that the potential to improve outcomes outweighs associated expenses. Healthcarecare Finance News Feed